These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 30392378)

  • 1. Brain-Targeting Delivery of Two Peptidylic Inhibitors for Their Combination Therapy in Transgenic Polyglutamine Disease Mice via Intranasal Administration.
    Yang M; Zhang Q; Wang Q; Sørensen KK; Boesen JT; Ma SY; Jensen KJ; Kwan KM; Ngo JCK; Chan HYE; Zuo Z
    Mol Pharm; 2018 Dec; 15(12):5781-5792. PubMed ID: 30392378
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A brain-targeting lipidated peptide for neutralizing RNA-mediated toxicity in Polyglutamine Diseases.
    Zhang Q; Yang M; Sørensen KK; Madsen CS; Boesen JT; An Y; Peng SH; Wei Y; Wang Q; Jensen KJ; Zuo Z; Chan HYE; Ngo JCK
    Sci Rep; 2017 Sep; 7(1):12077. PubMed ID: 28935901
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessing a peptidylic inhibitor-based therapeutic approach that simultaneously suppresses polyglutamine RNA- and protein-mediated toxicities in patient cells and Drosophila.
    Zhang Q; Tsoi H; Peng S; Li PP; Lau KF; Rudnicki DD; Ngo JC; Chan HY
    Dis Model Mech; 2016 Mar; 9(3):321-34. PubMed ID: 26839389
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Delivery of the aggregate inhibitor peptide QBP1 into the mouse brain using PTDs and its therapeutic effect on polyglutamine disease mice.
    Popiel HA; Nagai Y; Fujikake N; Toda T
    Neurosci Lett; 2009 Jan; 449(2):87-92. PubMed ID: 18603372
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of protein misfolding/aggregation using polyglutamine binding peptide QBP1 as a therapy for the polyglutamine diseases.
    Popiel HA; Takeuchi T; Burke JR; Strittmatter WJ; Toda T; Wada K; Nagai Y
    Neurotherapeutics; 2013 Jul; 10(3):440-6. PubMed ID: 23504628
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SynB3 Conjugated QBP1 Passes Blood-Brain Barrier Models and Inhibits PolyQ Protein Aggregation.
    Zuo L; Li W; Shi J; Su Y; Shuai H; Yu X
    Protein Pept Lett; 2022; 29(1):110-120. PubMed ID: 34939535
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protein transduction domain-mediated delivery of QBP1 suppresses polyglutamine-induced neurodegeneration in vivo.
    Popiel HA; Nagai Y; Fujikake N; Toda T
    Mol Ther; 2007 Feb; 15(2):303-9. PubMed ID: 17235308
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevention of polyglutamine oligomerization and neurodegeneration by the peptide inhibitor QBP1 in Drosophila.
    Nagai Y; Fujikake N; Ohno K; Higashiyama H; Popiel HA; Rahadian J; Yamaguchi M; Strittmatter WJ; Burke JR; Toda T
    Hum Mol Genet; 2003 Jun; 12(11):1253-9. PubMed ID: 12761040
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficient brain uptake and distribution of an expanded CAG RNA inhibitor DB213 via intranasal administration.
    Wang Q; Peng S; Hu Y; Wong CH; Kwan KM; Chan HYE; Zuo Z
    Eur J Pharm Sci; 2019 Jan; 127():240-251. PubMed ID: 30391403
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Selective degradation of expanded polyglutamine proteins by their specific recognition with QBP1].
    Nagai Y; Nukina N
    Rinsho Shinkeigaku; 2011 Nov; 51(11):1108-10. PubMed ID: 22277499
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Neurodegenerative polyglutamine expansion diseases: physiopathology and therapeutic strategies].
    Ravache M; Abou-Sleymane G; Trottier Y
    Pathol Biol (Paris); 2010 Oct; 58(5):357-66. PubMed ID: 20299163
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polyglutamine disease: recent advances in the neuropathology of dentatorubral-pallidoluysian atrophy.
    Yamada M; Shimohata M; Sato T; Tsuji S; Takahashi H
    Neuropathology; 2006 Aug; 26(4):346-51. PubMed ID: 16961072
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CAG repeat disorder models and human neuropathology: similarities and differences.
    Yamada M; Sato T; Tsuji S; Takahashi H
    Acta Neuropathol; 2008 Jan; 115(1):71-86. PubMed ID: 17786457
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Aggregation Inhibitor Peptide QBP1 as a Therapeutic Molecule for the Polyglutamine Neurodegenerative Diseases.
    Popiel HA; Burke JR; Strittmatter WJ; Oishi S; Fujii N; Takeuchi T; Toda T; Wada K; Nagai Y
    J Amino Acids; 2011; 2011():265084. PubMed ID: 22312459
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hsp40 gene therapy exerts therapeutic effects on polyglutamine disease mice via a non-cell autonomous mechanism.
    Popiel HA; Takeuchi T; Fujita H; Yamamoto K; Ito C; Yamane H; Muramatsu S; Toda T; Wada K; Nagai Y
    PLoS One; 2012; 7(11):e51069. PubMed ID: 23226463
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insights into the molecular basis of polyglutamine neurodegeneration from studies of a spinocerebellar ataxia type 7 mouse model.
    Grote SK; La Spada AR
    Cytogenet Genome Res; 2003; 100(1-4):164-74. PubMed ID: 14526177
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel therapeutic strategy for polyglutamine diseases by stabilizing aggregation-prone proteins with small molecules.
    Tanaka M; Machida Y; Nukina N
    J Mol Med (Berl); 2005 May; 83(5):343-52. PubMed ID: 15759103
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure-activity relationship study on polyglutamine binding peptide QBP1.
    Tomita K; Popiel HA; Nagai Y; Toda T; Yoshimitsu Y; Ohno H; Oishi S; Fujii N
    Bioorg Med Chem; 2009 Feb; 17(3):1259-63. PubMed ID: 19121945
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanisms of chaperone suppression of polyglutamine disease: selectivity, synergy and modulation of protein solubility in Drosophila.
    Chan HY; Warrick JM; Gray-Board GL; Paulson HL; Bonini NM
    Hum Mol Genet; 2000 Nov; 9(19):2811-20. PubMed ID: 11092757
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nuclear speckles are detention centers for transcripts containing expanded CAG repeats.
    Urbanek MO; Jazurek M; Switonski PM; Figura G; Krzyzosiak WJ
    Biochim Biophys Acta; 2016 Sep; 1862(9):1513-20. PubMed ID: 27239700
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.